FFA
ONCY

Farther Finance Advisors’s Oncolytics Biotech ONCY Stock Holding History

Farther Finance Advisors’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.87K Buy
+3,023
New +$2.8K ﹤0.01% 5037

Other funds holding ONCY

EFG
Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return
DA
Doliver Advisors Houston, Texas $442M AUM 34.09% 1-Year Est. Return
PAS
Professional Advisory Services Vero Beach, Florida $836M AUM 25.79% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
CMA
Cedar Mountain Advisors Lake Oswego, Oregon $581M AUM 18.16% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return
DWM
Dogwood Wealth Management Lenexa, Kansas $253M AUM 19.41% 1-Year Est. Return
WWM
Wolff Wiese Magana Carslbad, California $217M AUM 47.64% 1-Year Est. Return

Farther Finance Advisors's ONCY Position: Q2 2026 in Review

Farther Finance Advisors opened a new position in Oncolytics Biotech (ONCY) in Q2 2026: 3,023 shares worth $2.87K. The stake represents ﹤0.01% of the portfolio and ranks #5037 among its holdings.

9 funds tracked by Wall St. Rank hold ONCY as of Q2 2026.

  • Farther Finance Advisors held 3,023 shares of Oncolytics Biotech worth $2.87K as of Q2 2026.
  • Oncolytics Biotech was a new Farther Finance Advisors position in Q2 2026.
  • Oncolytics Biotech made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #5037 holding.
  • 9 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.